Sfoglia per AUTORE
MESSORE B
Collezione AOU San Luigi di Orbassano

  

Items : 12

Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis. in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society / J Cyst Fibros. 2024 Mar;23(2):306-313. doi: 10.1016/j.jcf.2023.11.001. Epub 2023 Nov 8.
2024
AOU San Luigi di Orbassano

Dugac AV; Wege S; Verhulst S; Taccetti G; Pokojová E; Moreno RMG; Messore B; Fila L; Durieu I; Diamantea F; Burgel PR; Bourke S; Blasi F; Amorim A; Aliberti S; Gramegna A; Duff A; Southern KW; Castellani C;

Changes in exercise endurance and inspiratory capacity after lumacaftor/ivacaftor therapy in cystic fibrosis. in Pulmonology / Pulmonology. 2023 Jul-Aug;29(4):338-341. doi: 10.1016/j.pulmoe.2022.09.009. Epub 2022 Oct 21.
2023
AOU San Luigi di Orbassano

Savi D; Gramegna A; Vicenzi M; Di Paolo M; Messore B; Palange P; Blasi F; Savi D; Gramegna A; Vicenzi M; Di Paolo M; Messore B; Palange P; Blasi F;

The impact of elexacaftor/tezacaftor/ivacaftor therapy on the pulmonary management of adults with cystic fibrosis: An expert-based Delphi consensus. in Respiratory medicine / Respir Med. 2023 Dec;220:107455. doi: 10.1016/j.rmed.2023.107455. Epub 2023 Nov 3.
2023
AOU San Luigi di Orbassano

Gramegna A; Aliberti S; Calderazzo MA; Casciaro R; Ceruti C; Cimino G; Fabrizzi B; Lucanto C; Messore B; Pisi G; Taccetti G; Tarsia P; Blasi F; Cipolli M;

Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society. in Infection / Infection. 2022 Jun;50(3):671-679. doi: 10.1007/s15010-021-01737-z. Epub 2021 Dec 7.
2022
AOU San Luigi di Orbassano

Raia V; Riberi L; Poli P; Pizzamiglio G; Pisi G; Messore B; Mencarini V; Maschio M; Lucca F; Lucanto MC; Leonetti G; Leonardi S; Folino A; Ficili F; Francalanci M; Comello I; Collura M; Ciciriello F; Casciaro R; Bignamini E; Battistini F; Badolato R; Ambroni M; Alghisi F; Medino P; Daccò V; Cipolli M; Colombo C; Ros M; et alii...

CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis. in Cells / Cells. 2022 Apr 6;11(7):1243. doi: 10.3390/cells11071243.
2022
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Bignamini E; Esposito I; Loré NI; Messore B; Riberi L; Saluzzo F; De Rose V;

Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2021 Mar 22;10(3):338. doi: 10.3390/antibiotics10030338.
2021
AOU San Luigi di Orbassano

Taccetti G; Francalanci M; Pizzamiglio G; Messore B; Carnovale V; Cimino G; Cipolli M;

SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020. in PloS one / PLoS One. 2021 May 13;16(5):e0251527. doi: 10.1371/journal.pone.0251527. eCollection 2021.
2021
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Leonetti G; Lucanto MC; Messore B; Bignamini E; Pisi G; Francalanci M; Badolato R; Casciaro R; Morlacchi LC; Daccó V; Gagliano V; Maschio M; Alicandro G; Colombo C; Cipolli M;

Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function. in Respiratory medicine / Respir Med. 2020 Sep;171:106073. doi: 10.1016/j.rmed.2020.106073. Epub 2020 Jul 3.
2020
AOU San Luigi di Orbassano

Salvatore D; Terlizzi V; Francalanci M; Taccetti G; Messore B; Biglia C; Pisi G; Calderazzo MA; Caloiero M; Pizzamiglio G; Majo F; Cresta F; Leonetti G; De Venuto D;

The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone. in The clinical respiratory journal / Clin Respir J. 2019 Mar;13(3):166-173. doi: 10.1111/crj.12999.
2019
AOU San Luigi di Orbassano

Harari S; Caminati A; Confalonieri M; Poletti V; Vancheri C; Pesci A; Rogliani P; Luppi F; Agostini C; Rottoli P; Sanduzzi Zamparelli A; Sebastiani A; Della Porta R; Salton F; Messore B; Tomassetti S; Rosso R; Biffi A; Puxeddu E; Cerri S; Cinetto F; Refini RM; Bocchino M; Di Michele L; Specchia C; Albera C;

Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier. in Materials science & engineering. C, Materials for biological applications / Mater Sci Eng C Mater Biol Appl. 2019 Feb 1;95:19-28. doi: 10.1016/j.msec.2018.10.064. Epub 2018 Oct
2019
AOU San Luigi di Orbassano

Cristallini C; Barbani N; Ventrelli L; Summa C; Filippi S; Capelôa T; Vitale E; Albera C; Messore B; Giachino C;

Treatment compliance in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection treated with tobramycin inhalation powder: The FREE study. in Respiratory medicine / Respir Med. 2018 May;138:88-94. doi: 10.1016/j.rmed.2018.03.034. Epub 2018 Mar 31.
2018
AOU San Luigi di Orbassano

Blasi F; Carnovale V; Cimino G; Lucidi V; Salvatore D; Messore B; Bartezaghi M; Muscianisi E; Porpiglia PA;

2013
AOU San Luigi di Orbassano

Bianchi ML; Colombo C; Assael BM; Dubini A; Lombardo M; Quattrucci S; Bella S; Collura M; Messore B; Raia V; Poli F; Bini R; Albanese CV; De Rose V; Costantini D; Romano G; Pustorino E; Magazzù G; Bertasi S; Lucidi V; Traverso G; Coruzzo A; Grzejdziak AD;

©2024 Tutti i diritti riservati. Biblioteca Virtuale per la Salute - Piemonte